Dopamine/Serotonin Receptor Ligands. 9. Oxygen-Containing Midsized Heterocyclic Ring Systems and Nonrigidized Analogues. A Step toward Dopamine D5 Receptor Selectivity

Journal of Medicinal Chemistry
2004.0

Abstract

Eleven-membered heterocycles (dibenz[g,j]-1-oxa-4-azacycloundecenes) and open-chain analogues were synthesized and investigated for affinities to human dopamine receptor subtypes. The moderately rigidized rings displayed nanomolar and subnanomolar Ki values at D1-like receptors with a significant D1 to D2 and a slight D5 to D1 selectivity. The open-chain analogues showed lower affinities but significant D1 to D2 selectivities. Compound 3 (Ki(D5) = 0.57 nmol) showed antagonistic or inverse agonistic binding characteristics in a functional Ca assay.

Knowledge Graph

Similar Paper

Dopamine/Serotonin Receptor Ligands. 9. Oxygen-Containing Midsized Heterocyclic Ring Systems and Nonrigidized Analogues. A Step toward Dopamine D<sub>5</sub> Receptor Selectivity
Journal of Medicinal Chemistry 2004.0
Dibenzazecine scaffold rebuilding—Is the flexibility always essential for high dopamine receptor affinities?
Bioorganic &amp; Medicinal Chemistry 2009.0
Identification of C10 nitrogen-containing aporphines with dopamine D1 versus D5 receptor selectivity
Bioorganic &amp; Medicinal Chemistry Letters 2020.0
Investigation of various N-heterocyclic substituted piperazine versions of 5/7-{[2-(4-aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-2-ol: Effect on affinity and selectivity for dopamine D3 receptor
Bioorganic &amp; Medicinal Chemistry 2009.0
Evaluation of cis- and trans-9- and 11-Hydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridines as Structurally Rigid, Selective D1 Dopamine Receptor Ligands
Journal of Medicinal Chemistry 1995.0
Dopamine/Serotonin Receptor Ligands. 10: SAR Studies on Azecine-type Dopamine Receptor Ligands by Functional Screening at Human Cloned D<sub>1</sub>, D<sub>2L</sub>, and D<sub>5</sub> Receptors with a Microplate Reader Based Calcium Assay Lead to a Novel Potent D<sub>1</sub>/D<sub>5</sub> Selective Antagonist
Journal of Medicinal Chemistry 2006.0
Novel Analogues of (R)-5-(Methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one (Sumanirole) Provide Clues to Dopamine D<sub>2</sub>/D<sub>3</sub>Receptor Agonist Selectivity
Journal of Medicinal Chemistry 2016.0
Functionally Selective Dopamine D<sub>2</sub>, D<sub>3</sub>Receptor Partial Agonists
Journal of Medicinal Chemistry 2014.0
Binding and Preliminary Evaluation of 5-Hydroxy- and 10-Hydroxy-2,3,12,12a-tetrahydro-1H-[1]benzoxepino[2,3,4-ij]isoquinolines as Dopamine Receptor Ligands
Journal of Medicinal Chemistry 2000.0
Further delineation of hydrophobic binding sites in dopamine D2/D3 receptors for N-4 substituents on the piperazine ring of the hybrid template 5/7-{[2-(4-aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-2-ol
Bioorganic &amp; Medicinal Chemistry 2010.0